Turkey's pharmaceutical market is the third-largest in the Central and Eastern Europe (CEE) region, due to its considerable population size. Turkey's pharmaceutical expenditure per capita, at USD115 in 2017, is considerably lower than any EU member state. It ranks just 20th out of the 32 countries in the CEE region, trailing most markets aside from the former Soviet CIS markets.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive Landscape

Company Profile

Turkey Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology